DA
Danielle Antalffy UBS Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
26
Lantheus
LNTH
$3.72B
| $54.75 | $100 |
83%
upside
| Outperform | 3 years ago |
|
27
DexCom
DXCM
$31.6B
| $80.51 | $125 |
55%
upside
| Outperform | 3 years ago |
|
28
Boston Scientific
BSX
$159B
| $107.22 | $48 |
55%
downside
| Market Perform | 3 years ago |
|
29
Edwards Lifesciences
EW
$47.5B
| $80.94 | $138 |
71%
upside
| Outperform | 3 years ago |
|
30
Abbott
ABT
$231B
| $132.94 | $140 |
5%
upside
| Market Perform | 3 years ago |
|
31
Neuropace
NPCE
$322M
| $9.73 | $12 |
23%
upside
| Outperform | 3 years ago |
|
32
Procept Biorobotics
PRCT
$2.26B
| $40.68 | $30 |
26%
downside
| Outperform | 3 years ago |
|
33
Vericel Corp
VCEL
$1.72B
| $34.05 | $45 |
32%
upside
| Outperform | 3 years ago |
|
34
Inspire Medical Systems
INSP
$2.56B
| $86.46 | $273 |
216%
upside
| Outperform | 3 years ago |
|
35
Becton Dickinson
BDX
$55.1B
| $192.39 | $275 |
43%
upside
| Market Perform | 3 years ago |
|
36
Stryker
SYK
$150B
| $392.31 | $285 |
27%
downside
| Outperform | 3 years ago |
|
37
Medtronic
MDT
$119B
| $92.90 | $115 |
24%
upside
| Market Perform | 3 years ago |
|
38
Organogenesis Holdings
ORGO
$634M
| $5 | $20 |
300%
upside
| Outperform | 3 years ago |
|
39
Treace Medical Concepts
TMCI
$453M
| $7.17 | $32 |
346%
upside
| Outperform | 3 years ago |
|
40
Senseonics Holdings
SENS
$373M
| $0.4575 | $3 |
556%
upside
| Market Perform | 4 years ago |
|
41
Johnson & Johnson
JNJ
$430B
| $178.43 | $200 |
12%
upside
| Outperform | 4 years ago |
|
42
Baxter International
BAX
$12.5B
| $24.42 | $105 |
330%
upside
| Outperform | 5 years ago |
|